What top creators are saying about Centessa Pharmaceuticals plc(CNTA)

Biopharmaceutical company

1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.

Creator sentiment — last 30 days

Based on 1 scored insight about Centessa Pharmaceuticals plc.

Strongly bullish
avg +0.70
1 bullish0 neutral0 bearish

Top creators covering Centessa Pharmaceuticals plc (CNTA)

The 1 sources with the most insights about Centessa Pharmaceuticals plc on Kazuha.

Latest insights about Centessa Pharmaceuticals plc (CNTA)

AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.

Today

Very Bullish
Target: $6.3 billion acquisition

Recently acquired by Eli Lilly for its promising Orexin pathway treatments.

Discussed alongside Centessa Pharmaceuticals plc (CNTA)

Other assets that creators frequently mention in the same content as Centessa Pharmaceuticals plc.

Frequently asked

Which podcasters and creators cover Centessa Pharmaceuticals plc (CNTA) the most?

The most active sources covering Centessa Pharmaceuticals plc (CNTA) on Kazuha are PHD Ventures. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.

How many insights about Centessa Pharmaceuticals plc (CNTA) are on Kazuha?

Kazuha has indexed 1 AI-extracted insight about Centessa Pharmaceuticals plc (CNTA) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.

What other assets do creators discuss alongside Centessa Pharmaceuticals plc (CNTA)?

Creators covering Centessa Pharmaceuticals plc (CNTA) most frequently also discuss INTC, BABA, SPACE, LLY, RGTI. See the "Discussed alongside" section above for full asset pages.